Tag: bioequivalence standards
Arlyn Ackerman
Batch Variability and Bioequivalence: What Acceptable Limits Really Mean
Batch variability in pharmaceutical manufacturing can skew bioequivalence results, leading to incorrect approvals or rejections of generic drugs. Learn how regulators are updating standards to account for real-world manufacturing differences.
Continue Reading